Humana stock falls 18% amid Aetna acquisition doubts

Louisville, Ky.-based Humana’s share price dropped 18.6 percent from its June 21 high of $190.07 amid rising doubts its proposed acquisition by Hartford, Conn.-based Aetna will falter, the Hartford Courant reported.   

Advertisement

Investors are just beginning to return to the insurer after weeks of losses. Humana share prices closed at $161.30 Wednesday, a 4.3 percent increase for the day. Aetna’s stock also fell more than 4 percent since June 21, but saw a 3.2 percent increase Wednesday.

Stock changes reflect reports about the U.S. Department of Justice’s concerns regarding Aetna’s $37 billion acquisition of Humana, the Hartford Courant reported. Aetna executives met with top DOJ officials last Friday and presented the sale of its Medicare Advantage assets — valued around $1 billion — in hopes to soothe antitrust concerns.

More articles about payer issues:
6 strategies the last few co-ops are counting on to survive
In Florida, two long-term care insurers seek up to 114% rate increases
Providence Health & Services ends contract with Premera Blue Cross

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.